GlassScriptPhysician profile
Julia M Storti
NPI 1679683916
$7,834.21
in general payments reported to CMS, 2019-2025
32 companies · $2,334 in 2025
The $2,334 reported for 2025 was more than what 95% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $210 · 2022: $1,678 · 2023: $1,407 · 2024: $2,206 · 2025: $2,334.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,712 · Education: $234.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,712.21 |
| Education | $234.42 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,532.80 | 2021-2025 | |
| Genzyme Corporation | $797.64 | 2022-2025 | |
| Galderma Laboratories, L.P. | $437.95 | 2021-2025 | Aklief, Nemluvio, Twyneo |
| Mayne Pharma Commercial LLC | $423.40 | 2022-2025 | |
| Dermavant Sciences, INC. | $394.11 | 2022-2024 | Vtama |
| Ucb, INC. | $393.81 | 2022-2025 | Bimzelx |
| Sun Pharmaceutical Industries INC. | $375.59 | 2021-2025 | Absorica Ld, Winlevi |
| Arcutis Biotherapeutics, INC. | $373.38 | 2023-2025 | Zoryve |
| Regeneron Healthcare Solutions, INC. | $367.54 | 2022-2025 | Dupixent, Libtayo |
| Janssen Biotech, INC. | $359.71 | 2022-2025 | Tremfya |
| Leo Pharma INC. | $350.29 | 2022-2025 | Adbry |
| Incyte Corporation | $219.32 | 2021-2025 | Opzelura |
| Pfizer INC. | $215.86 | 2022-2025 | |
| Biofrontera INC. | $175.20 | 2022-2023 | Xepi, Bf-Rhodoled, Ameluz |
| Sanofi-Aventis U.S. LLC | $159.98 | 2024-2025 |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Almirall LLC | $131.69 | 2022-2025 | Klisyri |
| Organon LLC | $118.80 | 2025 | Vtama |
| Lilly USA, LLC | $114.79 | 2023-2025 | Taltz, Ebglyss, Olumiant |
| Amgen INC. | $108.39 | 2021-2025 | Otezla |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $105.61 | 2022-2025 | Jublia, Cabtreo, Arazlo |
| Epi Health, LLC | $98.49 | 2022 | |
| Botanix Sb INC | $90.83 | 2025 | Sofdra |
| Novartis Pharmaceuticals Corporation | $82.60 | 2021 | |
| E.R. Squibb & Sons, L.L.C. | $76.67 | 2022-2024 | Sotyktu |
| Genentech USA, INC. | $63.81 | 2023-2024 | Erivedge |
| Sebela Pharmaceuticals INC. | $51.13 | 2021-2022 | |
| Lnhc, INC | $48.84 | 2025 | Zelsuvmi |
| Journey Medical Corporation | $45.23 | 2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $42.19 | 2024-2025 | Spevigo |
| Verrica Pharmaceuticals INC. | $40.80 | 2024 | Ycanth |
| Cipher Pharmaceuticals US LLC | $22.16 | 2025 | Spinosad, Natroba |
| Fresenius Kabi USA, LLC | $15.60 | 2023 | Idacio |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Julia Storti listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.